Is hydroxychloroquine beneficial for COVID-19 patients?
Xing Li, Ying Wang, Patrizia Agostinis, Arnold Rabson, Gerry Melino, Ernesto Carafoli, Yufang Shi, Erwei Sun
Cell Death & Disease, doi:10.1038/s41419-020-2721-8
The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in December 2019. As similar cases rapidly emerged around the world 1-3 , the World Health Organization (WHO) declared a public health emergency of international concern on January 30, 2020 and pronounced the rapidly spreading coronavirus outbreak as a pandemic on March 11, 2020 4 . The virus has reached almost all countries of the globe. As of June 3, 2020, the accumulated confirmed cases reached 6,479,405 with more than 383,013 deaths worldwide. The urgent and emergency care of COVID-19 patients calls for effective drugs, in addition to the beneficial effects of remdesivir 5 , to control the disease and halt the pandemic. US FDA approved hydroxychloroquine (HCQ) and chloroquine (CQ) for COVID-19 as an Emergency Use Authorization (EUA) with cautions issued soon after
Conflict of interest The authors declare that they have no conflict of interest. Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
Al-Bari, Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases, J. Antimicrob. Chemother
An, Woodward, Sasaki, Minie, Elkon, Cutting edge: antimalarial drugs inhibit IFN-β production through blockade of cyclic GMP-AMP synthase-DNA interaction, J. Immunol
Ballabio, Bonifacino, Lysosomes as dynamic regulators of cell and organismal homeostasis, Nat. Rev. Mol. Cell Biol
Ben-Zvi, Kivity, Langevitz, Yehuda, Hydroxychloroquine: from malaria to autoimmunity, Clin. Rev. Allergy Immunol
Chatre, Cardiac complications attributed to chloroquine and hydroxychloroquine: a systematic review of the literature, Drug Saf
Chen, COVID-19 infection: the China and Italy perspectives, Cell Death Dis
Chung, Dysregulated autophagy contributes to caspase-dependent neuronal apoptosis, Cell Death Dis
Costedoat-Chalumeau, A critical review of the effects of hydroxychloroquine and chloroquine on the eye, Clin. Rev. Allergy Immunol
Costedoat-Chalumeau, Dunogué, Morel, Guern, Guettrot-Imbert, Hydroxychloroquine: a multifaceted treatment in lupus, Presse Med
Costedoat-Chalumeau, Heart conduction disorders related to antimalarials toxicity: an analysis of electrocardiograms in 85 patients treated with hydroxychloroquine for connective tissue diseases, Rheumatology
Dai, Chloroquine ameliorates carbon tetrachloride-induced acute liver injury in mice via the concomitant inhibition of inflammation and induction of apoptosis, Cell Death Dis
Devaux, New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?, Int. J. Antimicrob. Agents
Ferner, Aronson, Chloroquine and hydroxychloroquine in covid-19, BMJ
Fiehn, Safety management of the treatment with antimalarial drugs in rheumatology. Interdisciplinary recommendations based on a systematic literature search, Z. Rheumatol
Gao, Tian, Yang, Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies, Biosci. Trends
Gautret, Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, Int. J. Antimicrob. Agents,
doi:10.1016/j.ijantimicagGeleris, Observational study of hydroxychloroquine in hospitalized patients with Covid-19, N. Engl. J. Med,
doi:10.1056/NEJMoa2012410Gunst, Van Den Berghe, Intensive care nutrition and post-intensive care recovery, Crit. Care Clin
Han, Novel function of hydroxychloroquine: down regulation of T follicular helper cells in collagen-induced arthritis, Biomed. Pharmacother
Jorge, Hydroxychloroquine retinopathy-implications of research advances for rheumatology care, Nat. Rev. Rheumatol
Lau, RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement, J. Exp. Med
Lenzer, Covid-19: US gives emergency approval to hydroxychloroquine despite lack of evidence, BMJ
Li, Hypoxia-induced autophagy of stellate cells inhibits expression and secretion of lumican into microenvironment of pancreatic ductal adenocarcinoma, Cell Death Differ
Liu, Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro, Cell Discov
Maes, Tumor vessel normalization by chloroquine independent of autophagy, Cancer Cell
Mauthe, Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion, Autophagy
Mehra, Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis, The Lancet,
doi:10.1016/S0140-6736(20)31180-6Monteil, Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2, Cell
Morawski, Bolland, Expanding the B cell-centric view of systemic lupus erythematosus, Trends Immunol
Nguyen, Cardiovascular toxicities associated with hydroxychloroquine and azithromycin: an analysis of the world health organization pharmacovigilance database, Circulation,
doi:10.1161/CIRCULATIONAHA.120.048238Phua, Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations, Lancet Respir. Med
Rosenberg, Association of treatment with hydroxychloroquine or azithromycin with in-hospital mortality in patients with COVID-19 in New York State, JAMA,
doi:10.1001/jama.2020.8630Ruiz-Irastorza, Ramos-Casals, Brito-Zeron, Khamashta, Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review, Ann. Rheum. Dis
Sacre, Criswell, Mccune, Hydroxychloroquine is associated with impaired interferon-alpha and tumor necrosis factor-alpha production by plasmacytoid dendritic cells in systemic lupus erythematosus, Arthritis Res. Ther
Sawa, Doctors Face Sanctions for Prescribing Unproven Covid-19 Drugs to Friends and Family
Schrezenmeier, Dorner, Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology, Nat. Rev. Rheumatol
Sharma, BCG Vaccination Policy and preventive chloroquine usage: do they have an impact on COVID-19 pandemic?, Cell Death Dis
Shi, COVID-19 infection: the perspectives on immune responses, Cell Death Differ
Shimabukuro-Vornhagen, Cytokine release syndrome, J. Immunother. Cancer
Shu, Li, Li, The mechanism of double stranded DNA sensing through the cGAS-STING pathway, Cytokine Growth Factor Rev
Singh, Kumar, Aluri, Lenert, Interfering with B cells at the lupus tollway: promises, successes, and failed expectations, J. Allergy Clin. Immunol
Srinivasa, Tosounidou, Gordon, Increased incidence of gastrointestinal side effects in patients taking hydroxychloroquine: a brand-related issue?, J. Rheumatol
Tang, Hydroxychloroquine attenuates renal ischemia/reperfusion injury by inhibiting cathepsin mediated NLRP3 inflammasome activation, Cell Death Dis
Van Den Borne, Dijkmans, De Rooij, Cessie, Verwei, Chloroquine and hydroxychloroquine equally affect tumor necrosis factor-alpha, interleukin 6, and interferon-gamma production by peripheral blood mononuclear cells, J. Rheumatol
Vellingiri, COVID-19: a promising cure for the global panic, Sci. Total Environ
Vollmer, Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8, J. Exp. Med
Volpe, The RNA binding protein Sam68 controls T helper 1 differentiation and anti-mycobacterial response through modulation of miR-29, Cell Death Differ
Wallace, Linker-Israeli, Hyun, Klinenberg, Stecher, The effect of hydroxychloroquine therapy on serum levels of immunoregulatory molecules in patients with systemic lupus erythematosus, J. Rheumatol
Wang, Intestinal autophagy links psychosocial stress with gut microbiota to promote inflammatory bowel disease, Cell Death Dis
Wang, Lim, What is the role of hydroxychloroquine in reducing thrombotic risk in patients with antiphospholipid antibodies, Hematol. Am. Soc. Hematol. Educ. Program
Wang, Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro, Cell Res
Who, WHO Announces COVID-19 Outbreak a Pandemic (The World Health Organization
Wärri, Autophagy and unfolded protein response (UPR) regulate mammary gland involution by restraining apoptosis-driven irreversible changes, Cell Death Discov
Yam, Kwok, Ocular toxicity of hydroxychloroquine, Hong Kong Med. J
Yao, In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Clin. Infect. Dis,
doi:10.1093/cid/ciaa237Zamora, Paclitaxel induces lymphatic endothelial cells autophagy to promote metastasis, Cell Death Dis
Zhai, The epidemiology, diagnosis and treatment of COVID-19, Int. J. Antimicrob. Agents
Zhang, The cytosolic DNA sensor cGAS forms an oligomeric complex with DNA and undergoes switch-like conformational changes in the activation loop, Cell Rep
Zhitomirsky, Lysosomotropic drugs activate TFEB via lysosomal membrane fluidization and consequent inhibition of mTORC1 activity, Cell Death Dis
